Pharma Reviews: Dr Reddy's net profit declines by 56.6% in Q1, scrip tanks over 6%

Dr Reddy's Laboratories (DRL), a Rs.13,800 crore plus Indian pharma company, has received major setback during the first quarter ended June 2017 ...
Read more: Dr Reddy's net profit declines by 56.6% in Q1, scrip tanks over 6%